Novartis and other industry leaders call for action to address antimicrobial resistance, one of the world’s most serious public health challenges
Novartis employs new technologies to cut greenhouse gas emissions, reduce water consumption and non-recyclable waste
Dr. George Vratsanos, rheumatologist and Executive Global Program Head at Novartis Pharmaceuticals, shares his team’s top five principles that are at the heart of our clinical trial program.
We asked patients for their feedback on an upcoming clinical trial in Australia. Here’s what they said.
We are partnering with the Friedrich Miescher Institute on more than 50 research projects to improve and extend people’s lives.
Thanks to their outstanding contributions to the Power of One campaign, three Novartis associates recently had the chance to travel to Kenya with the Novartis Malaria Initiative.
Patient Declaration covers commitments in five key areas
With ViaOpta Nav, visually impaired people can now use Apple watches and Android Wear devices to navigate to and from places with greater ease.
The winners of the fifth annual Novartis International BioCamp embarked on a trip to discover China, the prize for winning the BioCamp 2014 student competition.
On January 28, 2015, we published our 2014 Annual Report – including a comprehensive look back at our results and achievements in Corporate Responsibility during the year.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.